BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230620T080000
DTEND;TZID=America/Vancouver:20230623T170000
DTSTAMP:20230113T001015Z
CREATED:20230113T001015Z
LAST-MODIFIED:20230113T001015Z
UID:23312-1687248000-1687539600@scienceinboston.com
SUMMARY:FOCIS 2023
DESCRIPTION:FOCIS is THE meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides the unique opportunity for innovative thinking and applying ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study. \nThrough the FOCIS Annual Meeting\, researchers and clinicians share knowledge across traditional disease borders\, and identify commonalities between treatments and therapies that are life changing for those affected with immune-mediated diseases. From the introduction of monoclonal antibodies in clinical practice — to recent advances in cancer immunotherapy – the past two decades have been transformational for patients living with immune-mediated diseases. \nFOCIS 2023 will take place\, in person\, June 20-23\, 2023\, at the Boston Marriott Copley Place. \nYour Health and Safety\nYour health and safety remain a top priority to FOCIS. The Annual Meeting will be held fully in person\, and we are committed to keeping you safe.
URL:https://scienceinboston.com/event/focis-2023/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20230621T143000
DTEND;TZID=America/Vancouver:20230621T180000
DTSTAMP:20230613T214256Z
CREATED:20230613T214256Z
LAST-MODIFIED:20230613T214256Z
UID:25252-1687357800-1687370400@scienceinboston.com
SUMMARY:Unveiling the Power Within: Tumoroids for Translational IO Drug Discovery & Development
DESCRIPTION:Join Nilogen on June 21st from 3:00-6:00pm at the MassBio HUB for an event dedicated to the importance of the tumor microenvironment in translational drug discovery and development. The event will feature a two part plenary session with a presentation session and panel discussion\, followed by a networking reception featuring cocktails and hors d’oeuvres. \nAgenda:\n2:30-3:00pm: Registration & Networking \n3:00-3:05pm: Introduction \n3:05-3:35pm: Plenary Presentation: “Tumoroids for Translational Drug Discovery & Development”\nPresenter: Dr. Soner Altiok\, M.D. PhD\, Founder & CSO\, Nilogen Oncosystems \n3:35-4:20pm: Panel Discussion: “Challenges in IO Drug Discovery\, Development\, and Clinical Translation”\nModerator: Rikhia Chakraborty PhD\, VP\, R&D & Operations\, Nilogen Oncosystems\nPanelists: \n\nJohanna Kaufmann PhD\, EVP Oncology\, Codagenix\nShilpa Demes PhD\, Director\, Translational Science\, Astellas Pharma\nKhalid Shah M.S. PhD\, Vice Chairman of Research\, Neurosurgery\, Brigham & Women’s Hospital\nSoner Altiok M.D. PhD\, Founder & CSO\, Nilogen Oncosystems\n\n4:20-6:00pm: Networking Reception
URL:https://scienceinboston.com/event/unveiling-the-power-within-tumoroids-for-translational-io-drug-discovery-development/
LOCATION:MassBioHub\, 700 Technology Square\, Cambridge\, MA\, 02139\, United States
END:VEVENT
END:VCALENDAR